20-17969869-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_052865.4(MGME1):āc.10A>Cā(p.Lys4Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_052865.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MGME1 | NM_052865.4 | c.10A>C | p.Lys4Gln | missense_variant | 2/5 | ENST00000377710.10 | NP_443097.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MGME1 | ENST00000377710.10 | c.10A>C | p.Lys4Gln | missense_variant | 2/5 | 1 | NM_052865.4 | ENSP00000366939.5 | ||
MGME1 | ENST00000377709.1 | c.10A>C | p.Lys4Gln | missense_variant | 2/5 | 2 | ENSP00000366938.1 | |||
MGME1 | ENST00000377704.4 | c.10A>C | p.Lys4Gln | missense_variant | 2/3 | 3 | ENSP00000366933.4 | |||
OVOL2 | ENST00000486776.5 | n.492-12832T>G | intron_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000207 AC: 3AN: 1452410Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 722586
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2024 | The c.10A>C (p.K4Q) alteration is located in exon 2 (coding exon 1) of the MGME1 gene. This alteration results from a A to C substitution at nucleotide position 10, causing the lysine (K) at amino acid position 4 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.